论文部分内容阅读
目的观察匹多莫德在治疗小儿哮喘中的辅助疗效。方法根据患儿性别、年龄、严重程度选择性将哮喘患儿126例分为两组,对照组(63例)及观察组(63例);对照组应用中华医学会呼吸病学分会哮喘学组2008支气管哮喘防治指南治疗方案治疗;观察组在对照组的基础上给予匹多莫德口服,每次0.4,1次/d,连服60d为一疗程。治疗后比较两组临床疗效。结果观察组总有效率98.41%明显高于对照组77.78%。结论匹多莫德可以提高支气管哮喘患儿免疫力,控制哮喘的发作,具有良好的辅助治疗效果,值得临床推广应用。
Objective To observe the effect of pidotimod in the treatment of pediatric asthma. Methods According to the sex, age and severity of children, 126 children with asthma were divided into two groups randomly: the control group (63 cases) and the observation group (63 cases). The control group was treated with the asthma group of Respiratory Disease Branch of Chinese Medical Association 2008 guidelines for the treatment of bronchial asthma treatment treatment; observation group was given on the basis of the control group Pidotimod oral 0.4,1 times / d, and even served 60d for a course of treatment. After treatment, the clinical efficacy of the two groups were compared. Results The total effective rate in observation group was 98.41%, which was significantly higher than that in control group (77.78%). Conclusion Pidotimod can improve the immunity of children with bronchial asthma and control the onset of asthma. It has good adjuvant therapy and is worthy of clinical application.